Wearable tech offers hope for spotting dementia-causing diseases
By
Kristen Fischer
Mar 08, 2024
Wearable technology that measures spatial navigation and gait could improve detection of diseases that cause dementia, according to a new study.
Researchers pinpoint pre-diagnosis care paths in people with Alzheimer’s disease, other dementia
By
Kristen Fischer
Jan 26, 2024
Every person with Alzheimer’s disease and related dementias has a unique journey of how they discovered their diagnosis. A new study in Alzheimer’s & Dementia examined the patterns that led up...
Blood test accurate, consistent at spotting Alzheimer’s, dementia-linked proteins
By
Kristen Fischer
Jan 24, 2024
A new blood test that can spot amyloid and tau in the brain should be on the market soon. The test worked well to accurately and consistently identify accumulations of the proteins implicated in Alzheimer’s...
Cognitive decline prevention may start in the gut, study suggests
By
Kristen Fischer
Jul 25, 2023
Probiotics could aid in preventing cognitive decline that happens during aging, according to a study released at the American Society for Nutrition conference this week in Boston. The research could make...
Initial symptoms of dementia predict speed of progression, study finds
By
Alicia Lasek
Mar 16, 2023
No matter the type of underlying brain changes, the first cognitive symptoms of dementia help predict long-term functional outcomes, researchers report.
Study seeks to shed light on COVID-19’s impact on the brain
By
John Roszkowski
Sep 23, 2022
A global consortium of researchers is seeking to uncover the short-term and long-term impacts of COVID-19 on the brain to assess whether it can lead to cognitive impairments later in life such as Alzheimer’s...
Enrichment activities activate genes that help seniors resist cognitive decline
By
Amy Novotney
Nov 08, 2021
Spending time on intellectually stimulating activities appears to activate a gene family known as MEF2, which controls a genetic program in the brain that promotes resistance to cognitive decline. That’s...
Drugmakers ask FDA to approve another Alzheimer’s drug, similar to Aduhelm
By
Alicia Lasek
Sep 29, 2021
Drugmakers Eisai and Biogen are putting the Food and Drug Administration to the test with a request to approve a second Alzheimer’s drug that works like aducanumab (Aduhelm), the new, yet controversial,...